Crispr Therapeutics shares owned by Warren Averett Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Warren Averett Asset Management
from 13F filings
Historical chart of Warren Averett Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Warren Averett Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Warren Averett Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $933k | 14k | 64.81 |
| 2025-06-30 | $749k | 15k | 48.64 |
| 2025-03-31 | $519k | 15k | 34.03 |
| 2024-12-31 | $610k | 16k | 39.36 |
| 2024-09-30 | $911k | 19k | 46.98 |
| 2024-06-30 | $944k | 18k | 54.01 |
| 2024-03-31 | $619k | 9.1k | 68.16 |
| 2023-12-31 | $270k | 4.3k | 62.60 |
| 2023-06-30 | $256k | 4.6k | 56.14 |
More positions owned by Warren Averett Asset Management
View all positions for Warren Averett Asset Management